Risk factors associated with high linezolid trough plasma concentrations.

about

A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?

P2860

Q50719557-89F88593-F363-451C-BE06-8E7710546FB3

P2860

Risk factors associated with high linezolid trough plasma concentrations.

Item

http://www.wikidata.org/entity/Q40683242

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Risk factors associated with high linezolid trough plasma concentrations.

@en

type

Item

label

Risk factors associated with high linezolid trough plasma concentrations.

@en

prefLabel

Risk factors associated with high linezolid trough plasma concentrations.

@en

P1476

Risk factors associated with high linezolid trough plasma concentrations.

@en

P2093

C De la Calle

http://www.w3.org/2001/XMLSchema#string

J A Martínez

http://www.w3.org/2001/XMLSchema#string

J M Gómez-Cerquera

http://www.w3.org/2001/XMLSchema#string

J Mensa

http://www.w3.org/2001/XMLSchema#string

L Morata

http://www.w3.org/2001/XMLSchema#string

N Cobos-Trigueros

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance: clinical significance and treatment options.

Thrombocytopenia associated with linezolid therapy.

Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections.

Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.

Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.

Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction.

Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.

Correlation between serum linezolid concentration and the development of thrombocytopenia.

Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.

High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.

P304

1183-1187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2016.1182154

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27156708

http://www.w3.org/2001/XMLSchema#string

Risk factors associated with high linezolid trough plasma concentrations.

about

P2860

P2860

Risk factors associated with high linezolid trough plasma concentrations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698